John Demaree Karyopharm Therapeutics Inc. (KPTI) insider trading activity

KPTI Quotes by TradingView

John Demaree is Chief Commercial Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 23,995 shares of KPTI, which is worth approximately $15,356. The most recent transaction as insider was on Feb 25, 2021, when has been sold 15,849 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24K
0% 3M change
0% 12M change
Total Value Held $15,356

JOHN DEMAREE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2021
BUY
Grant, award, or other acquisition
-
15,849 Added 39.78%
23,995 Common Stock
JD

John Demaree

Chief Commercial Officer
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KPTI